New Drug ApprovalEMA CHMP December 2025 Meeting: 7 New Medicine Approvals and 12 Indication ... EMA CHMP December 2025 Meeting: 7 New Medicine Approvals and 12 Indication ... Read Post »
New Drug ApprovalFDA Approves Nuzolvence (Zoliflodacin): First-in-Class Oral Antibiotic for ... FDA Approves Nuzolvence (Zoliflodacin): First-in-Class Oral Antibiotic for ... Read Post »
Clinical TrailsEli Lilly’s Triple Agonist Retatrutide Hits Phase 3 Goals in Obesity ... Eli Lilly’s Triple Agonist Retatrutide Hits Phase 3 Goals in Obesity ... Read Post »
New Drug ApprovalFDA Approves First Cell-Based Therapy Waskyra for Rare WAS Immunodeficiency FDA Approves First Cell-Based Therapy Waskyra for Rare WAS Immunodeficiency Read Post »
New Drug ApprovalFDA’s First CNPV Approval: Augmentin XR Goes Domestic FDA’s First CNPV Approval: Augmentin XR Goes Domestic Read Post »
Drugs Safety Alert ResearchFDA Alerts on Fake Ozempic in Legitimate US Supply: Novo Nordisk Guidance A... FDA Alerts on Fake Ozempic in Legitimate US Supply: Novo Nordisk Guidance A... Read Post »
New Drug ApprovalFDA Qualifies First AI Tool under Drug Development Tool Program, Paving the... FDA Qualifies First AI Tool under Drug Development Tool Program, Paving the... Read Post »
New Drug ApprovalFDA Approves Omisirge for Severe Aplastic Anemia: A New Option for Patients... FDA Approves Omisirge for Severe Aplastic Anemia: A New Option for Patients... Read Post »
Clinical TrailsVertex CASGEVY Breakthrough: First Data in Children 5-11 at ASH 2025, Globa... Vertex CASGEVY Breakthrough: First Data in Children 5-11 at ASH 2025, Globa... Read Post »
Clinical TrailsBreakthrough Rusfertide Phase 3 VERIFY Results: 52-Week Hematocrit Control ... Breakthrough Rusfertide Phase 3 VERIFY Results: 52-Week Hematocrit Control ... Read Post »
Lifestyle Research WellnessUnderstanding Cannabis: How Medical and Recreational Use Differ in Purpose,... Understanding Cannabis: How Medical and Recreational Use Differ in Purpose,... Read Post »
Clinical TrailsPfizer’s HYMPAVZI Shows 93% Bleed Reduction in Hemophilia A/B with Inhibi... Pfizer’s HYMPAVZI Shows 93% Bleed Reduction in Hemophilia A/B with Inhibi... Read Post »
Clinical TrailsZorevunersen Four-Year Results Confirm Disease-Modifying Potential in Pedia... Zorevunersen Four-Year Results Confirm Disease-Modifying Potential in Pedia... Read Post »
Health Tidings ResearchFDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... FDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... Read Post »
Clinical TrailsJnJ’s INLEXZO™ Achieves 74% One-Year Disease-Free Survival in BCG-U... JnJ’s INLEXZO™ Achieves 74% One-Year Disease-Free Survival in BCG-U... Read Post »
Clinical TrailsBayer Launches Phase III SUNFLOWER Trial: Mirena 52mg LNG-IUS for Nonatypic... Bayer Launches Phase III SUNFLOWER Trial: Mirena 52mg LNG-IUS for Nonatypic... Read Post »
Clinical TrailsPositive HOPE-3 Phase 3 Results Support Deramiocel as a Potential New Treat... Positive HOPE-3 Phase 3 Results Support Deramiocel as a Potential New Treat... Read Post »
Health Tidings ResearchAbbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Abbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Read Post »
New Drug ApprovalFDA Approves Breyanzi as First CAR T-Cell Therapy for Relapsed/Refractory M... FDA Approves Breyanzi as First CAR T-Cell Therapy for Relapsed/Refractory M... Read Post »
Clinical Trails New Drug ApprovalIonis’ Zilganersen Earns FDA Breakthrough Therapy Designation for Ultra R... Ionis’ Zilganersen Earns FDA Breakthrough Therapy Designation for Ultra R... Read Post »
Clinical TrailsLEQEMBI® (Lecanemab-irmb) CTAD 2025 Data Confirms Aβ Protofibril Reductio... LEQEMBI® (Lecanemab-irmb) CTAD 2025 Data Confirms Aβ Protofibril Reductio... Read Post »
New Drug ApprovalSun Pharma Launches Ilumya® in India: A Global Innovative Drug for Moderat... Sun Pharma Launches Ilumya® in India: A Global Innovative Drug for Moderat... Read Post »
New Drug ApprovalBaxdrostat NDA Accepted Under FDA Priority Review for Hard-to-Control High ... Baxdrostat NDA Accepted Under FDA Priority Review for Hard-to-Control High ... Read Post »
Drugs Safety Alert ResearchFDA Seizes 73,000 Illegal 7-OH Opioid Products worth $1M in Missouri: Major... FDA Seizes 73,000 Illegal 7-OH Opioid Products worth $1M in Missouri: Major... Read Post »
Drugs Safety Alert ResearchFDA Final Guidance on QTc Information in Human Prescription Drug and Biolog... FDA Final Guidance on QTc Information in Human Prescription Drug and Biolog... Read Post »
New Drug ApprovalAmneal Secure FDA Nod for Albuterol Inhaler and Cyclosporine Eye Drops in E... Amneal Secure FDA Nod for Albuterol Inhaler and Cyclosporine Eye Drops in E... Read Post »
Clinical TrailsEisai Unveils Breakthrough Etalanetug Data at CTAD 2025: Significant Reduct... Eisai Unveils Breakthrough Etalanetug Data at CTAD 2025: Significant Reduct... Read Post »
New Drug ApprovalUS FDA Accepts Wockhardt’s NDA for Zaynich, Marking a Historic First for ... US FDA Accepts Wockhardt’s NDA for Zaynich, Marking a Historic First for ... Read Post »
Clinical TrailsMerck Presents Promising First-in-Human Data for Alzheimer’s Candidates M... Merck Presents Promising First-in-Human Data for Alzheimer’s Candidates M... Read Post »
Clinical TrailsAbbVie’s Phase 3 ECLIPSE Study Shows Atogepant (AQUIPTA®) Superior t... AbbVie’s Phase 3 ECLIPSE Study Shows Atogepant (AQUIPTA®) Superior t... Read Post »
Health Tidings ResearchEli Lilly Lowers Single-Dose Zepbound Vial Prices Eli Lilly Lowers Single-Dose Zepbound Vial Prices Read Post »
Drugs Safety Alert ResearchAustralia’s TGA Updates Safety Warnings for GLP-1 Receptor Agonists a... Australia’s TGA Updates Safety Warnings for GLP-1 Receptor Agonists a... Read Post »
ResearchWHO Measles Report 2025: Vaccination Triumphs save Millions but Outbreaks W... WHO Measles Report 2025: Vaccination Triumphs save Millions but Outbreaks W... Read Post »
Clinical TrailsOral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Oral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Read Post »
New Drug ApprovalChina’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... China’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... Read Post »
Clinical Trails Health TidingsAlexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Alexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Read Post »
New Drug ApprovalTreating ADHD Across Lifespan: Otsuka’s Centanafadine NDA Submission Insi... Treating ADHD Across Lifespan: Otsuka’s Centanafadine NDA Submission Insi... Read Post »
New Drug ApprovalEisai Completes Fast Track sBLA to FDA and Submits NDA to Japan PMDA for Su... Eisai Completes Fast Track sBLA to FDA and Submits NDA to Japan PMDA for Su... Read Post »
New Drug ApprovalFDA Accelerates Approval of Otsuka’s VOYXACT® (sibeprenlimab-szsi) for I... FDA Accelerates Approval of Otsuka’s VOYXACT® (sibeprenlimab-szsi) for I... Read Post »
Clinical Trails New Drug ApprovalNovo Nordisk Files FDA sNDA for Wegovy 7.2 mg Higher Dose After 20.7% Weigh... Novo Nordisk Files FDA sNDA for Wegovy 7.2 mg Higher Dose After 20.7% Weigh... Read Post »
New Drug ApprovalFDA Approves Imfinzi as First and Only Perioperative Immunotherapy for Earl... FDA Approves Imfinzi as First and Only Perioperative Immunotherapy for Earl... Read Post »
New Drug ApprovalSanofi and Regeneron’s Dupixent Wins EU Approval as First Targeted Therap... Sanofi and Regeneron’s Dupixent Wins EU Approval as First Targeted Therap... Read Post »
Drugs Safety Alert ResearchAbbott Initiates Medical Device Correction for Freestyle Libre 3 Sensors in... Abbott Initiates Medical Device Correction for Freestyle Libre 3 Sensors in... Read Post »
Clinical TrailsSarepta Receives FDA Approval to Begin ENDEAVOR Cohort 8 Investigating Enha... Sarepta Receives FDA Approval to Begin ENDEAVOR Cohort 8 Investigating Enha... Read Post »
New Drug ApprovalSerum Institute of India’s SIILTIBCY® Receives MHRA Authorization in... Serum Institute of India’s SIILTIBCY® Receives MHRA Authorization in... Read Post »
Clinical TrailsNovo Nordisk’s Amycretin Phase 2 Trial Shows Up to 14.5% Weight Loss and ... Novo Nordisk’s Amycretin Phase 2 Trial Shows Up to 14.5% Weight Loss and ... Read Post »
New Drug ApprovalFDA Approves Itvisma (Onasemnogene Abeparvovec-brve), the First Intrathecal... FDA Approves Itvisma (Onasemnogene Abeparvovec-brve), the First Intrathecal... Read Post »
Clinical TrailsJohnson & Johnson’s Posdinemab Fails to Meet Primary Endpoint in Auτ... Johnson & Johnson’s Posdinemab Fails to Meet Primary Endpoint in Auτ... Read Post »
Clinical TrailsKyowa Kirin Launches Phase 3 AOBA Study of KK8398 (Infigratinib) for Achond... Kyowa Kirin Launches Phase 3 AOBA Study of KK8398 (Infigratinib) for Achond... Read Post »
Clinical TrailsSarepta’s SRP-1003 siRNA Program Hits Key Enrollment Milestone, Triggers ... Sarepta’s SRP-1003 siRNA Program Hits Key Enrollment Milestone, Triggers ... Read Post »
